These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 1150543)
1. Cyclonucleoside derivatives of formycin. Makabe O; Nakamura M; Umezawa S J Antibiot (Tokyo); 1975 Jun; 28(6):492-5. PubMed ID: 1150543 [No Abstract] [Full Text] [Related]
2. Cyclic phosphates of formycin. Makabe O; Miyadera A; Kinoshita M; Umezawa S J Antibiot (Tokyo); 1978 May; 31(5):456-67. PubMed ID: 209007 [TBL] [Abstract][Full Text] [Related]
3. Formycin anhydronucleosides. Conformation of formycin and conformational specificity of adenosine deaminase. Zemlicks J J Am Chem Soc; 1975 Oct; 97(20):5896-903. PubMed ID: 1159245 [No Abstract] [Full Text] [Related]
4. Preparation and properties of formycin analogues methylated on the pyrazolo ring nitrogens and/or the ribose cis-hydroxyls. Giziewicz J; Shugar D Acta Biochim Pol; 1977; 24(3):231-46. PubMed ID: 930515 [TBL] [Abstract][Full Text] [Related]
5. Analogues of formycins A and B: synthesis and some properties of methyl derivatives of 7-amino and 7-keto pyrazolo(4,3-d)pyrimidines. Wierzchowski J; Kuśmierek J; Giziewicz J; Salvi D; Shugar D Acta Biochim Pol; 1980; 27(1):35-56. PubMed ID: 7435076 [TBL] [Abstract][Full Text] [Related]
6. Theoretical study of the protonation and tautomerization of adenosine, formycin, and their 2-NH2 and 2-F derivatives: functional implications in the mechanism of reaction of adenosine deaminase. Orozco M; Canela EI; Franco R Mol Pharmacol; 1989 Feb; 35(2):257-64. PubMed ID: 2537460 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of C nucleosides X. Structural analogs of formycin B. Huynh-Dinh T; Kolb A; Gouyette C; Igolen J J Org Chem; 1975 Sep; 40(19):2825-30. PubMed ID: 1177066 [No Abstract] [Full Text] [Related]
8. A fluorometric-high-performance liquid chromatographic assay procedure for several enzymatic activities using formycin analogs of adenosine 5'-mono, 5'-tri, and cyclic 3',5'-monophosphate as substrates. Rossomando EF; Jahngen J; Eccleston JF Anal Biochem; 1981 Sep; 116(1):80-8. PubMed ID: 6272613 [No Abstract] [Full Text] [Related]
9. Antiviral and antimetabolic activities of formycin and its N1-, N2-, 2'-O- and 3'-O-methylated derivatives. Giziewicz J; De Clercq E; Luczak M; Shugar D Biochem Pharmacol; 1975 Oct; 24(19):1813-7. PubMed ID: 184795 [No Abstract] [Full Text] [Related]
10. 2-Fluoroformycin and 2-aminoformycin. Synthesis and biological activity. Secrist JA; Shortnacy AT; Montgomery JA J Med Chem; 1985 Nov; 28(11):1740-2. PubMed ID: 4068000 [TBL] [Abstract][Full Text] [Related]
11. Synthesis of 5-chloroformycin A, 5-chloro-2'-deoxyformycin A and certain related 5,7-disubstituted 3-beta-D-ribofuranosylpyrazolo[4,3-d] pyrimidines from formycin A. Upadhya KG; Sanghvi YS; Robins RK; Revankar GR; Ugarkar BG Nucleic Acids Res; 1986 Feb; 14(4):1747-64. PubMed ID: 3951995 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of naturally occurring C-nucleosides, their analogs, and functionalized C-glycosyl precursors. Hanessian S; Pernet AG Adv Carbohydr Chem Biochem; 1976; 33():111-88. PubMed ID: 793324 [No Abstract] [Full Text] [Related]
13. Pyrazolo[4,3-d]pyrimidine nucleosides. Synthesis and antiviral activity of 1-beta-D-ribofuranosyl-3-methyl-6-substituted-7H-pyrazolo[4,3-d]pyr imi din-7-ones. Baraldi PG; Simoni D; Periotto V; Manfredini S; Guarneri M; Manservigi R; Cassai E; Bertolasi V J Med Chem; 1984 Aug; 27(8):986-90. PubMed ID: 6086926 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new adenosine deaminase inhibitor, isocoformycin, on toxicity, antitumor activity and tissue distribution of formycin A and 9-beta-D-arabinofuranosyladenine. Hidaka T; Katayama K; Yamashita K; Yamashita T; Watanabe K; Shimazaki M; Ohno M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Mar; 33(3):303-9. PubMed ID: 7380742 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antitumor activity of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines related to formycin prepared via ring closure of a 1,2,4-triazine precursor. Ramasamy K; Ugarkar BG; McKernan PA; Robins RK; Revankar GR J Med Chem; 1986 Nov; 29(11):2231-5. PubMed ID: 3783585 [TBL] [Abstract][Full Text] [Related]
16. Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin. De Clercq E; Balzarini J; Madej D; Hansske F; Robins MJ J Med Chem; 1987 Mar; 30(3):481-6. PubMed ID: 3820218 [TBL] [Abstract][Full Text] [Related]
17. N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cells. Crabtree GW; Agarwal RP; Parks RE; Lewis AF; Wotring LL; Townsend LB Biochem Pharmacol; 1979 May; 28(9):1491-500. PubMed ID: 475858 [No Abstract] [Full Text] [Related]
18. Improved synthesis of 2'-deoxyformycin A and studies of its in vitro activity against mouse lymphoma of T-cell origin. Rosowsky A; Solan VC; Gudas LJ J Med Chem; 1985 Aug; 28(8):1096-9. PubMed ID: 3874961 [TBL] [Abstract][Full Text] [Related]